Drug Profile
Crinecerfont - Neurocrine Biosciences
Alternative Names: NBI-74788; SSR 125543A - Neurocrine Biosciences; SSR-125543 - Neurocrine BiosciencesLatest Information Update: 05 Mar 2024
Price :
$50
*
At a glance
- Originator Sanofi
- Developer Neurocrine Biosciences; Sanofi
- Class Amines; Antidepressants; Anxiolytics; Chlorobenzenes; Cyclopropanes; Fluorobenzenes; Halogenated hydrocarbons; Phenyl ethers; Small molecules; Thiazines; Thiazoles
- Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Congenital adrenal hyperplasia
- Discontinued Major depressive disorder; Post-traumatic stress disorders